Page 84 - MI-2-1

Microbes & Immunity Childhood brucellosis in Saudi Arabia

and Infectious Diseases 2020. Available at: https:// doi: 10.4103/0256-4947.81543
www.researchgate.net/profile/Daire-Cantillon/ 12. Tsolia M, Drakonaki S, Messaritaki A, et al. Clinical
publication/341164914_ECCMID_2020_abstract_book/ features, complications and treatment outcome of childhood
links/5eb1c41445851592d6bd3ff0/ECCMID-2020- brucellosis in central Greece. J Infect. 2002;44(4):257-262.
abstract-book.pdf.
doi: 10.1053/jinf.2002.1000
References 13. Lubani M, Sharda D, Helin I. Brucella arthritis in children.
Infection. 1986;14(5):233-236.
1. Percin D. Microbiology of Brucella. Recent Pat Antiinfect
Drug Discov. 2013;8(1):13-17. doi: 10.1007/BF01644269
2. Corbel MJ. Brucellosis in Humans and Animals. Geneva: 14. Al Mofleh IA, Al Aska AI, Al Sekait MA, Al Balla SR, Al
World Health Organization; 2006. Nasser AN. Brucellosis in Saudi Arabia: Epidemiology in the
central region. Ann Saudi Med. 1996;16(3):349-352.
3. Al Anazi M, AlFayyad I, AlOtaibi R, Abu-Shaheen A.
Epidemiology of brucellosis in Saudi Arabia. Saudi Med J. doi: 10.5144/0256-4947.1996.349
2019;40(10):981-988. 15. El-Koumi MA, Afify M, Al-Zahrani SH. A prospective study
doi: 10.15537/smj.2019.10.24027 of brucellosis in children: Relative frequency of pancytopenia.
Mediterr J Hematol Infect Dis. 2013;5(1):e2013011.
4. Bukhari EE. Pediatric brucellosis. An update review for the
new millennium. Saudi Med J. 2018;39(4):336-341. doi: 10.4084/mjhid.2013.011
doi: 10.15537/smj.2018.4.21896 16. Pourakbari B, Abdolsalehi M, Mahmoudi S, Banar M,
Masoumpour F, Mamishi S. Epidemiologic, clinical, and
5. Laine CG, Johnson VE, Scott HM, Arenas-Gamboa AM.
Global estimate of human brucellosis incidence. Emerg laboratory characteristics of childhood brucellosis: A
Infect Dis. 2023;29(9):1789-1797. study in an Iranian children’s referral hospital. Wien Med
Wochenschr. 2019;169(9-10):232-239.
doi: 10.3201/eid2909.230052
doi: 10.1007/s10354-019-0685-z
6. Alghafeer MH, Aldhukair EF, Alzahrani AH, et al.
Assessment of knowledge, attitude, and practice related to 17. Adam A, Macdonald A, MacKenzie IG. Monarticular
brucellosis among livestock farmers and meat handlers in brucellar arthritis in children. J Bone Joint Surg Br.
1967;49(4):652-657.
Saudi Arabia. Front Vet Sci. 2024;11:1410330.
18. Erdem H, Elaldi N, Ak O, et al. Genitourinary brucellosis:
doi: 10.3389/fvets.2024.1410330
Results of a multicentric study. Clin Microbiol Infect.
7. Alshaalan MA, Alalola SA, Almuneef MA, et al. Brucellosis 2014;20(11):O847-O853.
in children: Prevention, diagnosis and management doi: 10.1111/1469-0691.12680
guidelines for general pediatricians endorsed by the Saudi
Pediatric Infectious Diseases Society (SPIDS). Int J Pediatr 19. Vallianou NG, Geladari E, Trigkidis K, Kokkinakis E.
Adolesc Med. 2014;1(1):40-46. Pyelonephritis due to Brucella species: True clinical entity or
ghost disease? New Microbes New Infect. 2017;15:33-34.
doi: 10.1016/j.ijpam.2014.09.004
doi: 10.1016/j.nmni.2016.10.001
8. Purwar S, Metgud SC, Mutnal MB, Nagamoti MB, Patil CS.
Utility of serological tests in the era of molecular testing for 20. Alsubaie SA, Turkistani SA, Zeaiter AA, Thabit AK. Lack of
diagnosis of human brucellosis in endemic area with limited correlation of Brucella antibody titers with clinical outcomes
resources. J Clin Diagn Res. 2016;10(2):DC26-DC29. and culture positivity of brucellosis. Trop Dis Travel Med
Vaccines. 2021;7(1):5.
doi: 10.7860/JCDR/2016/15525.7311
doi: 10.1186/s40794-021-00130-w
9. Memish ZA, Almuneef M, Mah MW, Qassem LA, Osoba AO.
Comparison of the Brucella standard agglutination test with 21. Al-Eissa Y, Al-Nasser M. Haematological manifestations of
the ELISA IgG and IgM in patients with Brucella bacteremia. childhood brucellosis. Infection. 1993;21(1):23-26.
Diagn Microbiol Infect Dis. 2002;44(2):129-132.
doi: 10.1007/bf01739305
doi: 10.1016/s0732-8893(02)00426-1
22. Sanaei Dashti A, Karimi A, Javad V, et al. ELISA cut-off point
®
10. Pfizer. Product Information: VIBRAMYCIN , Doxycycline for the diagnosis of human brucellosis; A comparison with
Hyclate Oral Capsules. New York: Pfizer, Inc.; 2019. serum agglutination test. Iran J Med Sci. 2012;37(1):9-14.
11. Zamani A, Kooraki S, Mohazab RA, et al. Epidemiological 23. Almuneef M, Memish ZA. Persistence of Brucella antibodies
and clinical features of Brucella arthritis in 24 children. Ann after successful treatment of acute brucellosis in an area of
Saudi Med. 2011;31(3):270-273. endemicity. J Clin Microbiol. 2002;40(6):2313.

Volume 2 Issue 1 (2025) 76 doi: 10.36922/mi.4634